Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1975 1
1976 1
1977 1
1979 3
1981 2
1982 1
1983 1
1984 1
1985 2
1986 1
1987 2
1989 2
1990 3
1992 1
1993 1
1995 3
1996 3
1997 5
1998 8
1999 8
2000 4
2001 11
2002 8
2003 8
2004 7
2005 9
2006 5
2007 7
2008 7
2009 3
2010 4
2011 2
2012 10
2013 4
2014 6
2015 7
2016 5
2017 6
2018 10
2019 7
2020 2
2021 10
2022 4
2023 3
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

187 results

Results by year

Filters applied: . Clear all
Page 1
Association Between Use of Pharmacokinetic-Interacting Drugs and Effectiveness and Safety of Direct Acting Oral Anticoagulants: Nested Case-Control Study.
Gronich N, Stein N, Muszkat M. Gronich N, et al. Clin Pharmacol Ther. 2021 Dec;110(6):1526-1536. doi: 10.1002/cpt.2369. Epub 2021 Aug 10. Clin Pharmacol Ther. 2021. PMID: 34287842 Free PMC article.
Each case of: (i) serious bleeding event; (ii) stroke/systemic emboli (SE) in patients with AF; (iii) recurrent thromboembolism in patients with thromboembolism, was matched by age, sex, length of follow-up, year of cohort entry, DOAC type, and DOAC indication, to u …
Each case of: (i) serious bleeding event; (ii) stroke/systemic emboli (SE) in patients with AF; (iii) recurrent thromboembolism …
Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer.
Lee AY, Levine MN, Baker RI, Bowden C, Kakkar AK, Prins M, Rickles FR, Julian JA, Haley S, Kovacs MJ, Gent M; Randomized Comparison of Low-Molecular-Weight Heparin versus Oral Anticoagulant Therapy for the Prevention of Recurrent Venous Thromboembolism in Patients with Cancer (CLOT) Investigators. Lee AY, et al. N Engl J Med. 2003 Jul 10;349(2):146-53. doi: 10.1056/NEJMoa025313. N Engl J Med. 2003. PMID: 12853587 Free article. Clinical Trial.
RESULTS: During the six-month study period, 27 of 336 patients in the dalteparin group had recurrent venous thromboembolism, as compared with 53 of 336 patients in the oral-anticoagulant group (hazard ratio, 0.48; P=0.002). The probability of recurrent thromboembolism …
RESULTS: During the six-month study period, 27 of 336 patients in the dalteparin group had recurrent venous thromboembolism, as compared wit …
Antiphospholipid antibody syndrome.
Lim W. Lim W. Hematology Am Soc Hematol Educ Program. 2009:233-9. doi: 10.1182/asheducation-2009.1.233. Hematology Am Soc Hematol Educ Program. 2009. PMID: 20008203 Review.
Anti-thrombotic therapy is the mainstay of treatment given the high risk of recurrent thromboembolism that characterizes this condition. Despite the prothrombotic nature of APS, thrombocytopenia is present in a proportion of patients. which can complicate management …
Anti-thrombotic therapy is the mainstay of treatment given the high risk of recurrent thromboembolism that characterizes this …
Anticoagulation in the elderly.
Henderson MC, White RH. Henderson MC, et al. Curr Opin Pulm Med. 2001 Sep;7(5):365-70. doi: 10.1097/00063198-200109000-00020. Curr Opin Pulm Med. 2001. PMID: 11584191 Review.
Anticoagulation in elderly patients poses unique challenges for the practicing clinician because they are simultaneously at higher risk for recurrent thromboembolism and major bleeding, including catastrophic intracranial hemorrhage. ...
Anticoagulation in elderly patients poses unique challenges for the practicing clinician because they are simultaneously at higher risk for …
Cancer and Venous Thromboembolic Disease: A Review.
Donnellan E, Khorana AA. Donnellan E, et al. Oncologist. 2017 Feb;22(2):199-207. doi: 10.1634/theoncologist.2016-0214. Epub 2017 Feb 7. Oncologist. 2017. PMID: 28174293 Free PMC article. Review.
Although low-molecular-weight heparin has been shown to be superior to vitamin K antagonists in cancer patients, the role of direct oral anticoagulants is still uncertain. Moreover, recurrent thromboembolism, bleeding, and thrombocytopenia are frequently seen in can …
Although low-molecular-weight heparin has been shown to be superior to vitamin K antagonists in cancer patients, the role of direct oral ant …
Antiphospholipid antibodies in critical illness.
Dentali F, Crowther M. Dentali F, et al. Crit Care Med. 2010 Feb;38(2 Suppl):S51-6. doi: 10.1097/CCM.0b013e3181c9e363. Crit Care Med. 2010. PMID: 20083914 Review.
Antithrombotic therapies are the mainstay of treatment to reduce the risk of recurrent thromboembolism. Among patients with antiphospholipid antibodies, the absolute risk of new thrombosis developing is low in healthy patients without previous thrombotic events. ...
Antithrombotic therapies are the mainstay of treatment to reduce the risk of recurrent thromboembolism. Among patients with an …
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia.
De Cobelli F, Palumbo D, Ciceri F, Landoni G, Ruggeri A, Rovere-Querini P, D'Angelo A, Steidler S, Galli L, Poli A, Fominskiy E, Calabrò MG, Colombo S, Monti G, Nicoletti R, Esposito A, Conte C, Dagna L, Ambrosio A, Scarpellini P, Ripa M, Spessot M, Carlucci M, Montorfano M, Agricola E, Baccellieri D, Bosi E, Tresoldi M, Castagna A, Martino G, Zangrillo A. De Cobelli F, et al. J Cardiothorac Vasc Anesth. 2021 Dec;35(12):3631-3641. doi: 10.1053/j.jvca.2021.01.011. Epub 2021 Jan 13. J Cardiothorac Vasc Anesth. 2021. PMID: 33518461 Free PMC article.
The aim was to assess whether pulmonary vascular thrombosis (PVT) is due to recurrent thromboembolism from peripheral deep vein thrombosis or to local inflammatory endothelial damage, with a superimposed thrombotic late complication. ...
The aim was to assess whether pulmonary vascular thrombosis (PVT) is due to recurrent thromboembolism from peripheral deep vei …
Recurrent thromboembolism in cancer patients: incidence and risk factors.
Prandoni P, Piccioli A, Pagnan A. Prandoni P, et al. Semin Thromb Hemost. 2003 Dec;29 Suppl 1:3-8. doi: 10.1055/s-2003-45411. Semin Thromb Hemost. 2003. PMID: 14730471 Review.
In contrast with the paucity of data on the risk of a first episode of thrombosis in cancer patients, the frequency of recurrent thromboembolism in patients with malignancy has been extensively investigated, both during anticoagulation and after its cessation. Cance …
In contrast with the paucity of data on the risk of a first episode of thrombosis in cancer patients, the frequency of recurrent t …
187 results